EichorEICHOR
Study identifier: NCT04027868 Synced from ClinicalTrials.gov · August 02, 2026
● Completed

Genomic BRCA and Extensive ovArian Cancer Testing

Condition: Epithelial Ovarian Cancer · Peritoneal Cancer · Fallopian Tube Cancer  ·  Sponsor: ARCAGY/ GINECO GROUP

PhaseN/A
Planned participants1500
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective observational French multicenter cohort in patients with ovarian and/or primitive peritoneal and/or fallopian tubes carcinoma, histologically confirmed, with an advanced stage at diagnosis (stage III to IV FIGO 2014). The objective is to constitute a clinico-biological database that allows to correlate clinical and progressive features of ovarian cancer patients based on tumor genomics and molecular detected abnormalities.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (137)

Centre de Radiothérapie et d'Oncologie de Moyenne Garonne (CROMG)Agen, France
Hôpital Privé d'Aix en ProvenceAix-en-Provence, France
Centre Hospitalier Général d'Aix-en-ProvenceAix-en-Provence, France
CHU AmiensAmiens, France
Clinique Victor PAUCHETAmiens, France
Institut de Cancérologie de l'Ouest - ICOAngers, France
Hôpital Privé d'Antony - Ramsay SantéAntony, France
CH ArrasArras, France
CH AuxerreAuxerre, France
Institut Sainte CatherineAvignon, France
Clinique BelharraBayonne, France
CH Côte BasqueBayonne, France

+ 125 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →